KMS Medisurgi Ltd (KMSMEDI)

About

KMS Medisurgi Ltd operates in Medical Equipment & Supplies within the Healthcare sector.

Face value: ₹10

Market cap

—

P/E

—

P/B

—

Dividend yield

0%

ROE

—

ROCE

—

Debt / equity

—

OPM

7.4%

EPS (TTM)

—

Book value

—

52-week high

—

52-week low

—

122 historical price candles were omitted because the exchange source has not been verified.

Only one verified price point is available. The trend chart will appear when more exchange closes are stored.

Quick read

rule-based

Pros

+High promoter holding of 74.4% with no pledge

Cons

−Thin operating margin of 7.4%

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	14	14	12
COGS	11	11	9
Gross profit	3	3	3
	2	2	2
Operating profit (EBITDA)	1	1	1
OPM %	5.6%	6.7%	7.4%
Depreciation	0	0	0
Interest	0	0	0
	0	0	0
Profit before tax	1	1	0
Tax	0	0	0
Tax %	25%	27.9%	24.2%
	0	0	0
PAT margin %	3.2%	3.2%	2.1%
EPS (₹)	1.4	1.3	0.7
	3.6%	3.8%	6.8%
Annual report	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2024	Mar 2025	Mar 2026
Equity capital	—	—	—
Reserves	—	—	—
Borrowings	—	—	—
	11	10	11
Total equity & liabilities	11	10	11
Fixed assets	—	2	3
CWIP	—	—	—
Investments	0	0	0
	11	9	8
Total assets	11	10	11

₹ Cr	Mar 2024	Mar 2025	Mar 2026
	1	1	2
	-1	-1	-1
	-0	0	-0
Net cash flow	0	0	1
Free cash flow	1	1	-0
CFO / Operating profit %	155.1%	79.6%	167.8%

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: -12%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: -43%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	22.6%	24.3%	27.8%
EBITDA margin %	5.6%	6.7%	7.4%
EBIT margin %	3.8%	4.7%	3.5%
PAT margin %	3.2%	3.2%	2.1%
Working capital
Receivable days	—	—	—
Inventory days	71	87	105
Payable days	—	—	—
NWC days	—	—	—
Leverage
Current ratio	3.37	5.46	5.01
Debt to EBITDA	—	—	—
Debt to equity	—	—	—
Interest coverage	31	8.6	4
Asset turnover	1.28	1.35	1.16
Return ratios
Return on assets %	4.1%	4.3%	2.4%
Return on capital employed %	7.6%	8%	4.9%
Return on equity %	—	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.42%	74.42%	74.42%	74.42%	74.42%	74.42%	74.42%	74.42%
FII	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%
	25.58%	25.58%	25.58%	25.58%	25.58%	25.58%	25.58%	25.58%
No. of shareholders	59	59	59	67	64	64	64	63

Promoter holding up 0 percentage points since Sep 2024.

Siddharth KanakiaManaging Director
Kamlesh Chunilal RajaniIndependent Director
Hardik Rajnikant BhattIndependent Director
Mr. Rohan Devang KanakiaNon-Executive Non-Independent Director
Mr. Anand Prataprai KanakiaChief Financial Officer
Mr. Gaurang Prataprai KanakiaNon-Executive Non-Independent Director
Ms. Monali KanakiaExecutive Director
Mrs. Pooja SoniCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in KMS Medisurgi Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

12

Annual reports

9

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

3

Final dividend23 Sept 2026 · ex-date₹0.05
Final dividend23 Sept 2025 · ex-date₹0.05
Final dividend23 Sept 2024 · ex-date₹0.05

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

12 announcementsExport CSV

1 Oct 2026, 11:43 amCompany Update

Announcement under Regulation 30 (LODR)-Cessation

Cessation PDF

1 Oct 2026, 11:35 amCompany Update

Announcement under Regulation 30 (LODR)-Cessation

Cessation PDF

30 Sept 2026, 4:58 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

30 Sept 2026, 3:57 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

29 Sept 2026, 6:18 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

8 Sept 2026, 7:16 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

5 Sept 2026, 3:59 pmCompany Update

Record Date For Payment Of Dividend

General PDF

5 Sept 2026, 3:52 pmCorp. Action

Corporate Action-Board approves Dividend

Dividend PDF

Date	Category	Subject	Filing
1 Oct 2026, 11:43 am	Company Update Cessation	Announcement under Regulation 30 (LODR)-Cessation	PDF
1 Oct 2026, 11:35 am	Company Update Cessation	Announcement under Regulation 30 (LODR)-Cessation

Loading announcements…

KMS Medisurgi Ltd

About

Quick read

Pros

Cons

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Dividends3

Announcements

Ratio timeline

Quarterly record

Board and management

No fund holdings on record

Dividends3

Not in the F&O segment

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

3

3